.avif)
Acute Blood Loss
Acute blood loss stresses oxygen delivery and circulatory stability. Early lab signals reveal falling red cell mass before symptoms escalate. At Superpower, we test Hemoglobin, Hematocrit, and RBC to quantify oxygen-carrying capacity and intravascular volume shifts, distinguishing true hemorrhage from dilutional changes and guiding timely clinical assessment.
Alcoholic Liver Disease
Alcoholic Liver Disease disrupts hepatocyte function, bile flow, and protein synthesis. Biomarker testing clarifies injury and reserve. At Superpower, we test for AST, ALT, GGT, Bilirubin, and Albumin to track hepatocellular damage, cholestasis, and synthetic capacity—helping map liver system health before complications.
Celiac Disease
Celiac disease damages intestinal villi, impairing nutrient absorption and provoking systemic inflammation. Biomarker testing helps reveal these effects early. At Superpower, we assess Hemoglobin and Ferritin for anemia, Folate and B12 for malabsorption, and ESR for inflammatory activity—together mapping gastrointestinal integrity and whole-body impacts.
Cholestasis
Cholestasis signals reduced bile flow, stressing the liver and biliary system and allowing bile salts and bilirubin to build up (hepatobiliary dysfunction). Targeted biomarkers detect this early. At Superpower, we test ALP, GGT, Bilirubin Direct, and BAR for Cholestasis to map cholestatic patterns and differentiate intrahepatic from obstructive causes.
Cirrhosis
Cirrhosis disrupts liver architecture and function, affecting protein synthesis, detoxification, and portal blood flow. Biomarker testing tracks this physiology in real time. At Superpower, we measure Albumin, Total Protein, Bilirubin, Platelets, and AST/ALT to assess synthetic capacity, cholestasis, portal hypertension risk, and hepatocellular injury.
